Phase I pharmacologic and biologic study of ramucirumab (IMC-1121B), a fully human immunoglobulin G1 monoclonal antibody targeting the vascular endothelial growth factor receptor-2.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Laura Q M Chow Roger B Cohen Sami Diab Jennifer L Spratlin D Ross Camidge Lia Gore Stephen Leong S Gail Eckhardt |
| Publication date | January 4, 2010 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |